NanoViricides
NNVC
#10069
Rank
โ‚น2.41 B
Marketcap
โ‚น111.92
Share price
2.48%
Change (1 day)
-9.49%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2025 (TTM): -โ‚น52.14

According to NanoViricides's latest financial reports the company's current EPS (TTM) is -โ‚น55.06. In 2024 the company made an earnings per share (EPS) of -โ‚น63.18 an increase over its 2023 EPS that were of -โ‚น66.79.

EPS history for NanoViricides from 2005 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น52.14-17.47%
2024-โ‚น63.18-5.41%
2023-โ‚น66.795.71%
2022-โ‚น63.18-13.58%
2021-โ‚น73.11-66.11%
2020-โ‚น215.711.7%
2019-โ‚น212.10-10.98%
2018-โ‚น238.28-22.35%
2017-โ‚น306.87-10.53%
2016-โ‚น342.97375%
2015-โ‚น72.20-85.19%
2014-โ‚น487.3842.11%
2013-โ‚น342.9726.67%
2012-โ‚น270.77-6.25%
2011-โ‚น288.8214.28%
2010-โ‚น252.72100%
2009-โ‚น126.36-0%
2008-โ‚น126.36-33.33%
2007-โ‚น189.54-0%
2006-โ‚น189.544445.07%
2005-โ‚น4.17

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
BioCryst Pharmaceuticals
BCRX
-โ‚น4.51-91.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น191.34-447.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น588.47-1,168.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น268.06-586.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น685.38-1,344.88%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น324.55-689.50%๐Ÿ‡ฌ๐Ÿ‡ง UK